InvestorsHub Logo
Post# of 252774
Next 10
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

Re: genisi post# 113722

Monday, 01/31/2011 1:27:45 PM

Monday, January 31, 2011 1:27:45 PM

Post# of 252774
>>MAPP/Allergan

Can anyone think of other examples where there has been a similar split with the drug developer retaining primary care and licensing out the specialty segment (here pain/neurologists)?

Peter
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.